Redmile Group, LLC - Q3 2012 holdings

$353 Million is the total value of Redmile Group, LLC's 51 reported holdings in Q3 2012. The portfolio turnover from Q2 2012 to Q3 2012 was - .

 Value Shares↓ Weighting
No holdings reported for quarter Q3 2012
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2012-12-03
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMICUS THERAPEUTICS INC43Q3 202310.1%
ATARA BIOTHERAPEUTICS INC36Q3 20236.4%
FATE THERAPEUTICS INC34Q3 202317.2%
INVITAE CORP32Q3 20232.7%
REGENXBIO INC28Q3 20233.8%
CLOVIS ONCOLOGY INC27Q1 20206.7%
IMMUNOGEN INC27Q3 202313.2%
CASTLIGHT HEALTH INC SAN FRAN COM STK27Q1 20212.5%
ARRAY BIOPHARMA INC26Q2 201912.6%
DECIPHERA PHARMACEUTICALS IN25Q3 20237.0%

View Redmile Group, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Redmile Group, LLC Q3 2012 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Neoleukin Therapeutics, Inc.July 27, 20232,912,2286.6%
IGM Biosciences, Inc.June 28, 20233,291,0929.9%
MedAvail Holdings, Inc.June 21, 2023124,507,26873.1%
Achilles Therapeutics plcFebruary 14, 20231,608,0893.9%
Kymera Therapeutics, Inc.February 14, 20232,673,8374.9%
Old Ayala, IncSold outFebruary 08, 202300.0%
Zymeworks Inc.August 08, 20225,758,2419.9%
Science 37 Holdings, Inc.June 15, 202219,808,23417.1%
Allakos Inc.February 14, 20222,077,8753.8%
Aprea Therapeutics, Inc.Sold outFebruary 14, 202200.0%

View Redmile Group, LLC's complete significant-ownership history.

Latest filings
TypeFiled
42024-06-21
42024-06-18
42024-06-14
42024-06-11
13F-HR2024-05-15
42024-05-10
42024-04-01
42024-04-01
42024-03-25
SC 13D/A2024-03-25

View Redmile Group, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (352885000.0 != 0.0)
  • The reported number of holdings is incorrect (51 != 0)
  • The reported has been restated
  • The reported has been amended

Export Redmile Group, LLC's holdings